Description
Additional file 4: Supplementary Fig. 4. Progression-free survival of patients with ETS ≥ 20% vs. ETS
| Dati resi disponibili | 2022 |
|---|---|
| Editore | figshare |
Additional file 4 of Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib
- Osman Öcal (Creatore)
- Regina Schinner (Creatore)
- Kerstin Schütte (Creatore)
- Enrico N. De Toni (Creatore)
- Christian Loewe (Creatore)
- Otto van Delden (Creatore)
- Vincent Vandecaveye (Creatore)
- Bernhard Gebauer (Creatore)
- Christoph J Zech (Creatore)
- Christian Sengel (Creatore)
- Irene Bargellini (Creatore)
- Antonio Gasbarrini (Creatore)
- Bruno Sangro (Creatore)
- Maciej Pech (Creatore)
- Peter Malfertheiner (Creatore)
- Jens Ricke (Creatore)
- Max Seidensticker (Creatore)
Dataset